|
|
Line 1: |
Line 1: |
| {{DrugProjectFormSinglePage
| |
| |authorTag={{chetan}}
| |
| |genericName=Rocuronium
| |
| |aOrAn=a
| |
| |drugClass=skeletal muscle relaxant and neuromuscular blockade
| |
| |indication=General anesthesia; Adjunct - Induction of neuromuscular blockade, During surgery or mechanical ventilation
| |
| Induction of neuromuscular blockade - Intubation, Routine tracheal.
| |
| Rapid sequence intubation
| |
| |adverseReactions= Cardiovascular: Hypertension (0.1% to 2% ), Hypotension (0.1% to 2% ), Tachycardia (less than 1% to 5.3% )
| |
| Dermatologic: Injection site pain
| |
| Respiratory: Increased pulmonary vascular resistance (24% )ns, separated by commas.
| |
| |blackBoxWarningTitle=Warning Title
| |
| |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
| |
| |fdaLIADAdult======Condition 1=====
| |
|
| |
|
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
| |offLabelAdultGuideSupport======Condition 1=====
| |
|
| |
| * Developed by: (Organisation)
| |
|
| |
| * Class of Recommendation: (Class) (Link)
| |
|
| |
| * Strength of Evidence: (Category A/B/C) (Link)
| |
|
| |
| * Dosing Information/Recommendation
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| * Developed by: (Organisation)
| |
|
| |
| * Class of Recommendation: (Class) (Link)
| |
|
| |
| * Strength of Evidence: (Category A/B/C) (Link)
| |
|
| |
| * Dosing Information/Recommendation
| |
|
| |
| :* (Dosage)
| |
| |offLabelAdultNoGuideSupport======Condition 1=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 3=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
| |fdaLIADPed======Condition 1=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
| |offLabelPedGuideSupport======Condition 1=====
| |
|
| |
| * Developed by: (Organisation)
| |
|
| |
| * Class of Recommendation: (Class) (Link)
| |
|
| |
| * Strength of Evidence: (Category A/B/C) (Link)
| |
|
| |
| * Dosing Information/Recommendation
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| * Developed by: (Organisation)
| |
|
| |
| * Class of Recommendation: (Class) (Link)
| |
|
| |
| * Strength of Evidence: (Category A/B/C) (Link)
| |
|
| |
| * Dosing Information/Recommendation
| |
|
| |
| :* (Dosage)
| |
| |offLabelPedNoGuideSupport======Condition 1=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
|
| |
| =====Condition 3=====
| |
|
| |
| * Dosing Information
| |
|
| |
| :* (Dosage)
| |
| |contraindications=* Condition 1
| |
| * Condition 2
| |
| * Condition 3
| |
| * Condition 4
| |
| * Condition 5
| |
| |warnings======Conidition 1=====
| |
|
| |
| (Description)
| |
| |clinicalTrials=======Central Nervous System======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Cardiovascular======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Respiratory======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Gastrointestinal======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Hypersensitive Reactions======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Miscellaneous======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| ======Central Nervous System======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Cardiovascular======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Respiratory======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Gastrointestinal======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Hypersensitive Reactions======
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| ======Miscellaneous======
| |
|
| |
| : (list/description of adverse reactions)
| |
| |postmarketing=(Description)
| |
| |drugInteractions=* Drug 1
| |
| * Drug 2
| |
| * Drug 3
| |
| * Drug 4
| |
| * Drug 5
| |
|
| |
| =====Drug 1=====
| |
|
| |
| (Description)
| |
|
| |
| =====Drug 2=====
| |
|
| |
| (Description)
| |
|
| |
| =====Drug 3=====
| |
|
| |
| (Description)
| |
|
| |
| =====Drug 4=====
| |
|
| |
| (Description)
| |
|
| |
| =====Drug 5=====
| |
|
| |
| (Description)
| |
| |useInPregnancyFDA=(Description)
| |
| |useInPregnancyAUS=(Description)
| |
| |useInLaborDelivery=(Description)
| |
| |useInNursing=(Description)
| |
| |useInPed=(Description)
| |
| |useInGeri=(Description)
| |
| |useInGender=(Description)
| |
| |useInRace=(Description)
| |
| |useInRenalImpair=(Description)
| |
| |useInHepaticImpair=(Description)
| |
| |useInReproPotential=(Description)
| |
| |useInImmunocomp=(Description)
| |
| |othersTitle=Others
| |
| |useInOthers=(Description)
| |
| |administration=(Oral/Intravenous/etc)
| |
| |monitoring======Condition 1=====
| |
|
| |
| (Description regarding monitoring, from ''Warnings'' section)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| (Description regarding monitoring, from ''Warnings'' section)
| |
|
| |
| =====Condition 3=====
| |
|
| |
| (Description regarding monitoring, from ''Warnings'' section)
| |
| |IVCompat====Solution===
| |
|
| |
| ====Compatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Not Tested====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Variable====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Incompatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ===Y-Site===
| |
|
| |
| ====Compatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Not Tested====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Variable====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Incompatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ===Admixture===
| |
|
| |
| ====Compatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Not Tested====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Variable====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Incompatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ===Syringe===
| |
|
| |
| ====Compatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Not Tested====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Variable====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Incompatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ===TPN/TNA===
| |
|
| |
| ====Compatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Not Tested====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Variable====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
|
| |
| ====Incompatible====
| |
|
| |
| * Solution 1
| |
| * Solution 2
| |
| * Solution 3
| |
| |overdose====Acute Overdose===
| |
|
| |
| ====Signs and Symptoms====
| |
|
| |
| (Description)
| |
|
| |
| ====Management====
| |
|
| |
| (Description)
| |
|
| |
| ===Chronic Overdose===
| |
|
| |
| ====Signs and Symptoms====
| |
|
| |
| (Description)
| |
|
| |
| ====Management====
| |
|
| |
| (Description)
| |
| |drugBox={{Drugbox2
| |
| | verifiedrevid =
| |
| | IUPAC_name =
| |
| | image =
| |
| | drug_name =
| |
|
| |
| <!--Clinical data-->
| |
| | tradename =
| |
| | MedlinePlus =
| |
| | licence_US =
| |
| | pregnancy_AU =
| |
| | pregnancy_US =
| |
| | legal_status =
| |
| | routes_of_administration =
| |
|
| |
| <!--Pharmacokinetic data-->
| |
| | bioavailability =
| |
| | metabolism =
| |
| | elimination_half-life =
| |
| | excretion =
| |
|
| |
| <!--Identifiers-->
| |
| | CAS_number_Ref =
| |
| | CAS_number =
| |
| | ATC_prefix =
| |
| | ATC_suffix =
| |
| | PubChem =
| |
| | IUPHAR_ligand =
| |
| | DrugBank_Ref =
| |
| | DrugBank =
| |
| | ChemSpiderID_Ref =
| |
| | ChemSpiderID =
| |
| | UNII_Ref =
| |
| | UNII =
| |
| | KEGG_Ref =
| |
| | KEGG =
| |
| | ChEBI_Ref =
| |
| | ChEBI =
| |
| | ChEMBL_Ref =
| |
| | ChEMBL =
| |
|
| |
| <!--Chemical data-->
| |
| | C= | H= | N= | O=
| |
| | molecular_weight =
| |
| | smiles =
| |
| | InChI =
| |
| | InChIKey =
| |
| | StdInChI_Ref =
| |
| | StdInChI =
| |
| | StdInChIKey_Ref =
| |
| | StdInChIKey =
| |
| | melting_point =
| |
| }}
| |
| |mechAction=(Description)
| |
| |structure=(Description with picture)
| |
| |PD=(Description)
| |
| |PK=(Description)
| |
| |nonClinToxic=(Description)
| |
| |clinicalStudies======Condition 1=====
| |
|
| |
| (Description)
| |
|
| |
| =====Condition 2=====
| |
|
| |
| (Description)
| |
|
| |
| =====Condition 3=====
| |
|
| |
| (Description)
| |
| |howSupplied=(Description)
| |
| |fdaPatientInfo=(Patient Counseling Information)
| |
| |alcohol=Alcohol-Rocuronium interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
| |
| |lookAlike=* (Paired Confused Name 1a) — (Paired Confused Name 1b)
| |
| * (Paired Confused Name 2a) — (Paired Confused Name 2b)
| |
| * (Paired Confused Name 3a) — (Paired Confused Name 3b)
| |
| |nlmPatientInfo=(Link to patient information page)
| |
| |drugShortage=Drug Shortage
| |
| }}
| |